Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets

Abstract

Background Pulpitis is an inflammatory disease, the grade of which is classified according to the level of inflammation. Traditional methods of evaluating the status of dental pulp tissue in clinical practice have limitations. The rapid and accurate diagnosis of pulpitis is essential for determining the appropriate treatment. By integrating different datasets from the Gene Expression Omnibus (GEO) database, we analysed a merged expression matrix of pulpitis, aiming to identify biological pathways and diagnostic biomarkers of pulpitis. Methods By integrating two datasets (GSE77459 and GSE92681) in the GEO database using the sva and limma packages of R, differentially expressed genes (DEGs) of pulpitis were identified. Then, the DEGs were analysed to identify biological pathways of dental pulp inflammation with Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Gene Set Enrichment Analysis (GSEA). Protein–protein interaction (PPI) networks and modules were constructed to identify hub genes with the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and Cytoscape. Results A total of 470 DEGs comprising 394 upregulated and 76 downregulated genes were found in pulpitis tissue. GO analysis revealed that the DEGs were enriched in biological processes related to inflammation, and the enriched pathways in the KEGG pathway analysis were cytokine-cytokine receptor interaction, chemokine signalling pathway and NF-κB signalling pathway. The GSEA results provided further functional annotations, including complement system, IL6/JAK/STAT3 signalling pathway and inflammatory response pathways. According to the degrees of nodes in the PPI network, 10 hub genes were identified, and 8 diagnostic biomarker candidates were screened: PTPRC, CD86, CCL2, IL6, TLR8, MMP9, CXCL8 and ICAM1. Conclusions With bioinformatics analysis of merged datasets, biomarker candidates of pulpitis were screened and the findings may be as reference to develop a new method of pulpitis diagnosis.

A critical analysis of research methods to study clinical molecular biomarkers in Endodontic research

“…biomarkers) that can be invariably linked to a disease or the outcome of a treatment (Naylor, 2003 ). It is also possible to identify a pattern of biomarkers that can be linked to a disease, a so‐called biosignature (Chen et al, 2020 ; MacLean et al, 2019 ). A useful way to classify biomarkers is thus to address their purpose (Winter et al, 2013 ) and the collection site (Fitzsimmons et al, 2010 ).…”

Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects

“…MMPs crucially contribute to all phases of tooth development, differentiation, growth, shaping, apoptosis and degradation of different dental and periodontal tissues. MMPs have become important as biomarkers of diseases including degradation of different dental tissues, reversible and irreversible pulpitis and apical periodontitis, as well as gingival and periodontal lesions [ 4 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ].…”

Meta-Analysis of Two Human RNA-seq Datasets to Determine Periodontitis Diagnostic Biomarkers and Drug Target Candidates

“…The development of RNA sequencing (RNA-seq) technology and bioinformatic tools have made it possible to investigate the changes in gene expression between healthy and diseased individuals to better elucidate the underlying mechanisms of observed pathologies. Transcriptomic analysis has also been used to identify biomarkers in cancer, chronic inflammatory diseases, and infectious diseases [ 33 , 34 , 35 ]. The public availability of transcriptomic datasets in the NCBI Gene Expression Omnibus (GEO) database enables researchers to perform meta-analyses on two or more datasets at a time [ 34 , 36 , 37 ].…”

“…Transcriptomic analysis has also been used to identify biomarkers in cancer, chronic inflammatory diseases, and infectious diseases [ 33 , 34 , 35 ]. The public availability of transcriptomic datasets in the NCBI Gene Expression Omnibus (GEO) database enables researchers to perform meta-analyses on two or more datasets at a time [ 34 , 36 , 37 ]. The processing of multiple datasets as part of a meta-analysis increases the number of samples in order to achieve higher statistical power and reduce biases that may be present in individual datasets [ 38 ].…”